GAMT

Chr 19AR

guanidinoacetate N-methyltransferase

Also known as: CCDS2, HEL-S-20, PIG2, TP53I2

This gene encodes guanidinoacetate N-methyltransferase, which converts guanidinoacetate to creatine using S-adenosylmethionine as the methyl donor. Mutations cause cerebral creatine deficiency syndrome 2, an autosomal recessive disorder characterized by neurologic abnormalities and muscular hypotonia due to creatine deficiency and guanidinoacetate accumulation in the brain. The gene shows tolerance to loss-of-function variants (low constraint), and affected individuals typically present in infancy or early childhood with developmental delays and seizures.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 1.261 OMIM phenotype
VCEP Guidelines: Cerebral Creatine DeficiencyReleased
View SpecificationsClinGen Panel
Clinical SummaryGAMT
🧬
Gene-Disease Validity (ClinGen)
guanidinoacetate methyltransferase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 49 VUS of 100 total submissions
📖
GeneReview available — GAMT
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.26LOEUF
pLI 0.009
Z-score 1.11
OE 0.55 (0.271.26)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.09Z-score
OE missense 1.02 (0.891.17)
153 obs / 150.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.55 (0.271.26)
00.351.4
Missense OE1.02 (0.891.17)
00.61.4
Synonymous OE1.00
01.21.6
LoF obs/exp: 4 / 7.2Missense obs/exp: 153 / 150.0Syn Z: 0.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGAMT-related guanidinoacetate methyltransferase deficiencyLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7131th %ile
GOF
0.5563th %ile
LOF
0.2091th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic12
Likely Pathogenic3
VUS49
Likely Benign36
12
Pathogenic
3
Likely Pathogenic
49
VUS
36
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
1
3
0
12
Likely Pathogenic
3
0
0
0
3
VUS
0
44
4
1
49
Likely Benign
0
0
16
20
36
Benign
0
0
0
0
0
Total11452321100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GAMT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →